MELISSA JACKSON: Open Payments
NPI 1497432868 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,788 in 94 payments from 14 companies in 2025. Trend: 2023 $396 · 2024 $1,890 · 2025 $1,788
Food & beverage: $1,688Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $528 |
| GENZYME CORPORATION | 9 | $261 |
| Janssen Biotech, Inc. | 11 | $179 |
| Amgen Inc. | 13 | $172 |
| LEO Pharma Inc. | 9 | $138 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $136 |
| Lilly USA, LLC | 8 | $131 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| UCB, Inc. | 2 | $40 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, OTEZLA, ADBRY, TALTZ, RINVOQ, COSENTYX.
Industry payments across KY — which companies pay providers there.
